Colin Hill

CEO and Co-founder Aitia

[Aitia @Aitiabio]

Honoring @RobertMMetcalfe, the father of the Ethernet, with a special reception. Distinguished leaders from Boston's innovation community celebrated Bob' transformative contributions to communication and connectivity. Congrats on the 2022 ACM #TuringAward!

[Aitia @Aitiabio]

We are live from the @RouxInstitute with @brucechurch presenting our session titled "Causal AI for Learning #DigitalTwins from Human Multi-Omic Data for #DrugDiscovery and Clinical Development: A Cardiovascular Disease Case Study"

[Colin Hill @ColinHill1]

I’m so happy and proud of friend, advisor, and mentor Bob Metcalfe for this long overdue recognition! Congrats Bob on the 2023 Turing Award!

[Aitia @Aitiabio]

Last year, we had the privilege of hosting Bob Metcalfe for a private fireside chat with our CEO @ColinHill1, and we couldn't be more proud to see him receive this year's #TuringAward for his incredible contributions to Ethernet. Congratulations, Bob!

[UCB News @ucb_news]

FOR MEDIA: #HealthcareInnovation requires investment in next gen science & technology. So, it’s great to announce an exciting #multiomics, #AI, #DrugDiscovery, #CausalAI collaboration with @Aitiabio

[Colin Hill @ColinHill1]

I am delighted to share that @Aitiabio and @ucb_news have announced a strategic #drugdiscovery collaboration focused on the discovery and validation of novel drug targets and drug candidates for #Huntingtondisease
More about this announcement: https://t.co/4yjxmWRfTH

[Aitia @Aitiabio]

Leaders in fields from chemistry to cancer research are among the Cambridge academics recognized at the #PlatinumJubilee. Congratulations to @adrian_weller, GNS board member awarded a special honor for his outstanding services to digital innovation. https://t.co/jubKkH6gvX

[Colin Hill @ColinHill1]

Exciting news! We are extremely happy to announce today our new partnership with @QIAGENBiox and their adoption of @gnshealthcare's Gemini – The in silico Patient™ across multiple cancers. https://t.co/9lQBMgOika

[Colin Hill @ColinHill1]

Excited to be moderating a panel tomorrow at the Longwood Healthcare Leaders Fall conference on Expediting the Path to Patient Care. I'll be joined by leaders from Bristol Myers Squibb, Illumina, BlackThorn Therapeutics, and Novartis.

[Colin Hill @ColinHill1]

Join me for the the #AI Applications for Drug Discovery and Development conference next week.

[Colin Hill @ColinHill1]

Excited to participate in this year's #STATHealthTech conference on 9/9-10. Other conference speakers include, Hal Barron of GSK and Levi Garraway of Roche. More details on the summit available here: https://t.co/y5ZH67sncp

[Colin Hill @ColinHill1]

I will be speaking at @MassBio's virtual #StateOfPossible Conference on 8/26-8/27! Join me as we debate the most pressing challenges facing the #LifeSciences to ensure we can continue its incredible success & improve #patient lives. To learn more, visit: https://t.co/JotXLei8PF

[Colin Hill @ColinHill1]

Looking forward to joining the other panelists at the conference and discuss how @gnshealthcare is impacting #PrecisionMedicine .

[STAT @statnews]

Speaker Announcement!
Colin Hill Chairman & CEO, GNS Healthcare

Learn more about our #STATHealthTEch Summit here: https://t.co/IUg9LIlT3q
@ColinHill1 #HealthTech

[Colin Hill @ColinHill1]

"AI vendors are believed to provide tangible impact on the improvement of the clinical study process." @BiopharmaTrend
GNS Healthcare was named a notable #AI company with capabilities to optimize the clinical development process. Read more here:

https://t.co/UnJOFwDeyz

[Colin Hill @ColinHill1]

Really enjoyed listening in on our webinar last week where the team dove into our work with CHDI on how we applied our #AI platform to discover biomarkers and subpopulations of disease progression in Huntington's. If you missed it, access it here: https://t.co/Rm8QvZUiGp

[Colin Hill @ColinHill1]

The presentation of our work is not only a validation of how #AI can extract critical insights from real-world data, but also a milestone in our mission to make precision #oncology a reality. https://t.co/OOQ2RiDEy4

[Colin Hill @ColinHill1]

Myeloma Research News covers the recent announcement of Gemini, the in silico patient. Read the piece here: https://t.co/0RI0Stcpxv

[Colin Hill @ColinHill1]

Looking forward to hearing from our team and partners at CHDI Foundation present on how we leveraged #AI to discover progression biomarkers and subpopulations in Huntington's Disease during our upcoming webinar. https://t.co/q6HiqAYtsD

[Colin Hill @ColinHill1]

Pleasure discussing Gemini, the in silico patient, and the impact of #AI in #pharma with Jacqueline Lisk for the @BostonGlobe.

https://t.co/OyB2q1KmP2

[Colin Hill @ColinHill1]

Precision #Oncology News, from @GenomeWeb covers Gemini, the in silico patient, and discusses our approach to reverse engineering and unraveling how multiple myeloma works.

Read more here: https://t.co/zftn3H91i0

[Colin Hill @ColinHill1]

@WSJ covers the #launch of Gemini and how we reconstruct underlying disease biology to simulate how patients respond to treatment. https://t.co/WauutrSwMW